Fig. 2: Kaplan–Meier overall survival curves.

a In CCUS, MDS, MDS/AML and AML, b in high-risk myeloid neoplasm with S34F and Q157P mutations and c in relation to bone marrow blast <10% vs ≥10%.
a In CCUS, MDS, MDS/AML and AML, b in high-risk myeloid neoplasm with S34F and Q157P mutations and c in relation to bone marrow blast <10% vs ≥10%.